Tag: Daniel Karelitz
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
Goodwin and Nelson Mullins in USD685m Crown LNG SPAC merger
Goodwin Procter and Nelson Mullins Riley & Scarborough have assisted the USD685 million merger of the Oslo-based liquefied natural gas (LNG) offshore terminal
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Goliath’s GC
TSMC general counsel Sylvia Fang charts rise of Taiwan’s semiconductor giant on the world stage and the multijurisdictional challenges
